About 300 reports

IV. INSULIN PRODUCTION AND DEMAND

  • Insulin
  • China
  • United States
  • Industrial Production
  • Labour Force

Insulin Resistance

  • Pharmaceutical
  • Insulin
  • World

Insulin Resistance – Overview

  • Insulin
  • World

##.## RYZODEG (INSULIN DEGLUDEC/INSULIN ASPART)

  • Insulin
  • Recombinant Insulin
  • Indiana
  • Diabetes Prevalence
  • Drug Approval

Insulin Resistance – Overview

  • Insulin
  • World

##.## INSULIN DRUGS

  • Insulin
  • Europe
  • Diabetes Prevalence
  • Mortality Rate

Abstract: - Global Insulin Storage Devices Market to Reach $1.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Insulin Storage Devices estimated at US$735 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 6.6% over the analysis period...

  • Insulin
  • World
  • China
  • United States

2021 Insulin Market - Size, Share, COVID Impact Analysis and Forecast to 2027 2021 Insulin Market - Size, Share, COVID Impact Analysis and Forecast to 2027 – is comprehensive research with in-depth data and contemporary analysis of Insulin Market at a global, regional and key country level, split by different sub-segments...

  • Insulin
  • World
  • APAC
  • Disposable Income

Major players in the smart insulin pens market are Companion Medical, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co. Ltd., Emperra GmbH E-Health Technologies, Digital Medics Pvt Ltd., F. Hoffmann-La Roche AG, Insulet Corporation, Jiangsu Delfu medical device Co. Ltd., and Bigfoot biomedical. The global smart insulin pens market...

  • Insulin Delivery
  • Insulin
  • United States
  • APAC
  • Medical Technology Density

Human Recombinant Insulin Market Report Overview Human Recombinant Insulin market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Human Recombinant Insulin market types and applications. It is a focused study on Human Recombinant Insulin market...

  • Protein Therapy
  • Insulin
  • World
  • APAC
  • Health Provider Density

The global human insulin market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 5% during the forecast period (2021-2026). Human insulin (HI) is a form of synthetic insulin that is synthesized in laboratories for pharmaceutical use. It is bio-engineered...

  • Recombinant Insulin
  • Insulin
  • World
  • Overweight Prevalence
  • Medicine Use

Major players in the insulin pens, syringes, pumps and injectors market are Novo Nordisk A/S (Denmark), Eli Lilly and Company, Medtronic plc (Ireland), Abbott, and Insulet Corporation (US). The global insulin pens, syringes, pumps and injectors market is expected to grow from $18.83 billion in 2020 to $19.26 billion in 2021 at a compound...

  • Insulin Delivery
  • Insulin
  • World
  • United States
  • Diabetes Prevalence

Rapid Acting Insulin Market by Product Type (Insulin Lispro, Insulin Aspart, and Insulin Glulisine), Indication (Type 1 Diabetes and Type 2 Diabetes), and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2020–2027 The...

  • Insulin
  • World
  • Diabetes Prevalence
  • Cause-Specific Mortality Rate

" Insulin Resistance - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for  Insulin Resistance. The marketed products information covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further provides the...

  • Insulin
  • Therapy
  • World
  • United States
  • Health Expenditure

The Global Insulin Storage Devices Market size is expected to reach $1.1 billion by 2026, rising at a market growth of 8.9% CAGR during the forecast period. Insulin is a naturally occurring, glucose-lowering hormone that is used by many diabetic people to regulate their blood sugar. For people with type 1 diabetes, supplementary insulin compensates...

  • Insulin
  • World
  • Asia
  • APAC

Smart Insulin or Glucose Responsive Insulin Market by Delivery Devices (Smart Insulin Pen and Smart Insulin Pump), Disease, (Type 1 Diabetes and Type 2 Diabetes), and Type (Rapid Acting, Intermediate Acting, Long Acting, Short Acting, and Premixed Type): Global Opportunity Analysis and Industry Forecast, 2019–2027 The...

  • Insulin
  • Insulin Delivery
  • World
  • APAC
  • North America
  • Diabetes Prevalence
  • Diabetes Incidence

##.##. INSULIN DELIVERY DEVICES – INSULIN SYRINGES

  • Insulin
  • Insulin Delivery
  • Diabetes Care
  • Diabetes Monitoring
  • Canada
  • Diabetes Prevalence
  • Drug Approval

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021 Summary Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis on Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) targeted pipeline therapeutics. The report...

  • Insulin
  • Research And Development
  • Drug Development
  • World

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 Summary Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1)...

  • Insulin
  • Research And Development
  • Drug Development
  • World

The ongoing clinical trial research report- “2019 Insulin Resistance Ongoing Clinical Trials Study” analyzes the current scenario of all active Insulin Resistance trials across the world. The report presents top level analysis of global Insulin Resistance clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Insulin
  • World
  • APAC

Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 Summary Cells Expressing Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis on Cells Expressing Insulin Like...

  • Insulin
  • Research And Development
  • Drug Development
  • World

2018 Future of Global Insulin Market To 2025- Growth Opportunities, Competition And Outlook Of Application And Regions Report Global Insulin markets are witnessing robust growth due to ongoing drive towards investments and plans for market expansion into developing countries. The year 2019 is expected to remain strong...

  • Insulin
  • World
  • Insulin Export

Abstract: - Global Polycystic Ovary Syndrome (PCOS) Treatment Market to Reach $4.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Polycystic Ovary Syndrome (PCOS) Treatment estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$4.6 Billion by 2027, growing at a CAGR...

  • Insulin
  • Contraceptive
  • World
  • China
  • United States

IV. INSULIN PRODUCTION AND DEMAND

  • Insulin
  • United States
  • Labour Force
  • Industrial Production

Novo Nordisk (China) Pharmaceutical Co., Ltd wholly owned by Denmark Novo Nordisk Co., Ltd, is the largest Insulin producer in China and in the world, which takes up more than ##% of China's Insulin market by its over ## million US dollar output.

  • Insulin
  • Pharmaceutical
  • China
  • United States
  • Diabetes Prevalence
  • Pharmaceutical Production

INSULIN DELIVERY DEVICES

  • Insulin
  • Veterinary Healthcare
  • Indiana
  • Diabetes Prevalence
  • Overweight Prevalence

INTRODUCTION Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....

  • Drug Delivery
  • Injectable Delivery
  • Insulin
  • World
  • Europe
  • APAC
  • North America
  • Number Of Enterprises
  • Chronic Disease Prevalence

Report Scope: The report provides a comprehensive summary of the Non-injectable insulin market, along with detailed profiles of key market players that include revenue product portfolios and recent activities.The report analyzes trends and dynamics, including drivers, limitations, challenges and opportunities. The...

  • Insulin
  • World
  • Export

Insulin Resistance Pipeline Overview The Q4 Insulin Resistance pipeline report is part of the VPA Metabolic Disorder disease pipeline service. This quarterly review describes the pipeline of drugs under development for Insulin Resistance, provides an update on the mechanism of action and targets, licensing and collaboration...

  • Therapy
  • Insulin
  • Drug Development
  • World

##. Insulin Delivery Devices:

  • Insulin
  • World
  • Health Expenditure
  • Drug Approval